Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs (Q61811125)

1

0 references

Maxim I Sorokin

2

0 references

Anna A Emelianova

3

0 references

Nikolay M Borisov

4

0 references

Denis V Kuzmin

5

0 references

Pieter Borger

6

0 references

Andrew V Garazha

7

0 references

Anton A Buzdin

Frontiers in Pharmacology

8

0 references

language of work or name

English

0 references

publication date

2019

0 references

published in

0 references

volume

10

0 references

page(s)

1

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

23 January 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ggplot2

object named as

ggplot2

2 references

10 June 2022

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&rettype=xml&id=6351482

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

KEGG: kyoto encyclopedia of genes and genomes

1 reference

12 December 2020

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

12 December 2020

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

12 December 2020

Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays

1 reference

12 December 2020

Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies

1 reference

12 December 2020

Targeting steroid hormone receptor pathways in the treatment of hormone dependent cancers

1 reference

12 December 2020

Targeted cancer therapy

1 reference

12 December 2020

Computational prediction of human metabolic pathways from the complete human genome

1 reference

12 December 2020

Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.

1 reference

12 December 2020

Targeting the kinase activity of the BCR-ABL fusion protein in patients with chronic myeloid leukemia

1 reference

12 December 2020

Targeting tyrosine kinases in cancer: the second wave

1 reference

12 December 2020

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

1 reference

12 December 2020

Structure-based maximal affinity model predicts small-molecule druggability.

1 reference

12 December 2020

Trastuzumab: triumphs and tribulations

1 reference

12 December 2020

Trastuzumab--mechanism of action and use in clinical practice

1 reference

12 December 2020

A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas

1 reference

12 December 2020

PID: the Pathway Interaction Database

1 reference

12 December 2020

Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma

1 reference

12 December 2020

Application of a new probabilistic model for mining implicit associated cancer genes from OMIM and medline

1 reference

12 December 2020

GeneCards Version 3: the human gene integrator

1 reference

12 December 2020

Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer

1 reference

12 December 2020

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence

1 reference

12 December 2020

Pharmacogenetics, pharmacogenomics, and individualized medicine

1 reference

12 December 2020

Analysis of pathway mutation profiles highlights collaboration between cancer-associated superpathways.

1 reference

12 December 2020

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

12 December 2020

CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma

1 reference

12 December 2020

Proteasome inhibitors: an expanding army attacking a unique target

1 reference

12 December 2020

Ten years of pathway analysis: current approaches and outstanding challenges

1 reference

12 December 2020

Explaining the unexplainable: EGFR antibodies in colorectal cancer

1 reference

12 December 2020

Target identification and mechanism of action in chemical biology and drug discovery

1 reference

12 December 2020

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

1 reference

12 December 2020

DrugBank 4.0: shedding new light on drug metabolism

1 reference

12 December 2020

The Reactome pathway knowledgebase

1 reference

12 December 2020

Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data.

1 reference

12 December 2020

Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial

1 reference

12 December 2020

Testicular cancer: a reflection on 50 years of discovery

1 reference

12 December 2020

PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer

1 reference

12 December 2020

Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities (review).

1 reference

12 December 2020

Drug resistance in cancer: an overview.

1 reference

12 December 2020

Towards identification of true cancer biomarkers

1 reference

12 December 2020

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer

1 reference

12 December 2020

Signaling pathways activation profiles make better markers of cancer than expression of individual genes.

1 reference

12 December 2020

Disialoganglioside GD2 as a therapeutic target for human diseases

1 reference

12 December 2020

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge

1 reference

12 December 2020

Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety

1 reference

12 December 2020

A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation

1 reference

12 December 2020

An overview of targeted cancer therapy

1 reference

12 December 2020

Non-small cell lung cancer: current treatment and future advances

1 reference

12 December 2020

mTOR inhibitors in cancer therapy

1 reference

12 December 2020

COSMIC: High-Resolution Cancer Genetics Using the Catalogue of Somatic Mutations in Cancer.

1 reference

12 December 2020

In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development.

1 reference

12 December 2020

COSMIC: somatic cancer genetics at high-resolution

1 reference

12 December 2020

Temporary portal vein embolization is as efficient as permanent portal vein embolization in mice.

1 reference

12 December 2020

Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data.

1 reference

12 December 2020

Mathematical Justification of Expression-Based Pathway Activation Scoring (PAS).

1 reference

12 December 2020

Bioinformatics Meets Biomedicine: OncoFinder, a Quantitative Approach for Interrogating Molecular Pathways Using Gene Expression Data

1 reference

12 December 2020

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors

1 reference

12 December 2020

A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information.

1 reference

12 December 2020

Clinical development of mTor inhibitors for renal cancer

1 reference

12 December 2020

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas

1 reference

12 December 2020

HMDB 4.0: the human metabolome database for 2018.

1 reference

12 December 2020

DGIdb 3.0: a redesign and expansion of the drug-gene interaction database.

1 reference

12 December 2020

Emergence of pathway-level composite biomarkers from converging gene set signals of heterogeneous transcriptomic responses

1 reference

12 December 2020

The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat

1 reference

12 December 2020

Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation.

1 reference

12 December 2020

Oncogenic Signaling Pathways in The Cancer Genome Atlas.

1 reference

12 December 2020

Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs

1 reference

12 December 2020

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

1 reference

12 December 2020

Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma

1 reference

12 December 2020